Loading company…

Merck & Co., Inc.

MRKCIK 000031015819 fiscal years, 70 SEC filings

RevenueFY2025

$65.01B1.3%

Net incomeFY2025

$18.25B6.6%

Free cash flowFY2025

$12.36B31.7%

Diluted EPSFY2025

$7.288.0%

Trends

FY2007–FY2025 · hover a year for its filing

Revenue & net incomeRevenueNet income

revenue 2.7× since FY2007 · net margin 13.5% → 28.1%

MarginsNet marginFCF margin

FY2025: net 28.1% · free cash flow 19.0% of revenue

Cash flowOperating cash flowFree cash flow

FY2025: $16.47B operating cash − $4.11B capex = $12.36B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 42% (FY2008) → 35% (FY2025) · on assets 13.3%

USD millions, except per-share values; share counts in millions. Click a value to open its filing; hover for the XBRL tag.

USD millions	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	65,011	64,168	60,115	59,283	48,704	41,518	39,121	42,294	40,122	39,807	39,498	42,237
Net income	18,254	17,117	365	14,519	13,049	7,067	9,843	6,220	2,394	3,920	4,442	11,920
Diluted EPS	7.28	6.74	0.14	5.71	5.14	2.78	3.81	2.32	0.87	1.41	1.56	4.07
Diluted shares	2,507	2,541	2,547	2,542	2,538	2,541	2,580	2,679	2,748	2,787	2,841	2,928
Operating cash flow	16,472	21,468	13,006	19,095	13,122	7,617	8,884	10,922	6,451	10,376	12,538	7,989
Capital expenditures	4,112	3,372	3,863	4,388	4,448	4,429	3,369	2,615	1,888	1,614	1,283	1,317
Free cash flow	12,360	18,096	9,143	14,707	8,674	3,188	5,515	8,307	4,563	8,762	11,255	6,672
Cash & equivalents	14,565	13,242	6,841	12,694	8,096	8,050	9,676	7,965	6,092	6,515	8,524	7,441
Total assets	136,866	117,106	106,675	109,160	105,694	91,588	84,397	82,637	87,872	95,377	101,677	98,167
Shareholders' equity	52,606	46,313	37,581	45,991	38,184	25,317	25,907	26,701	34,336	40,088	44,676	48,647

As reported in SEC filings; a missing tag shows “—”, never zero. Free cash flow is operating cash flow − capex. Methodology